Scholars Central

Conference abstractPublished 10 Sep 2012

Identification and mechanistic exploration of VentX as a novel tumor suppressor in lymphocytic leukemia

Authors: Hong Gao, Xiaoming Wu, Leslie Silberstein, Zhenglun Zhu

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The canonical Wnt/beta-catenin signaling has been viewed as a major oncogenic pathway, implicated in both solid and hematological malignancies. Wnt regulation is a target of intensive investigation for its potential application in cancer prevention and treatment. During our recent studies, we identified VentX, a human homologue of the Xenopus homeobox gene Xom of the BMP4 signaling pathway, as a novel Wnt antagonist and a putative tumor suppressor in lymphocytic leukemia. To further define the mechanism underlying tumor suppressor function of VentX, we performed a target screen to determine the potential effects of VentX on the expression of cell cycle regulators. We found that VentX activates the expression of genes involved in cellular senescence, such as the p53/p21 and Rb/p16. Combined approaches of biochemical and cellular studies showed that VentX is a direct activator of senescence pathway by binding to the promoters of p53 and p16. While, ectopic expression of VentX induce senescence phenotype in stable leukemic cell lines, inhibition of VentX induction by chemotherapeutic agents lead to chemo-resistance of leukemia cells. In summary, using methods of reverse genetics, we have identified VentX as a novel tumor suppressor. Our data showed that VentX is an antagonist of the oncogenic Wnt signaling and a direct activator of the senescence pathways of tumor suppression. As such, we propose that VentX functions as a pivotal link between oncogenic and tumor suppressing pathways and represents a novel target of intervention in the management of neoplastic diseases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Hong Gao”
  • BylineArticles whose byline prints “Xiaoming Wu”
  • BylineArticles whose byline prints “Leslie Silberstein”
  • BylineArticles whose byline prints “Zhenglun Zhu”